SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 455 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,547,000 | +107.1% | 13,996 | +40.5% | 0.05% | +92.9% |
| Q2 2022 | $747,000 | +55.3% | 9,962 | +61.9% | 0.03% | +75.0% |
| Q1 2022 | $481,000 | +40.6% | 6,154 | +62.2% | 0.02% | +33.3% |
| Q4 2021 | $342,000 | -50.7% | 3,795 | -49.4% | 0.01% | -47.8% |
| Q3 2021 | $694,000 | -72.1% | 7,503 | -57.6% | 0.02% | -91.3% |
| Q3 2020 | $2,485,000 | +495.9% | 17,696 | +580.1% | 0.26% | +473.9% |
| Q2 2020 | $417,000 | +134.3% | 2,602 | +10.1% | 0.05% | -9.8% |
| Q3 2019 | $178,000 | +17700.0% | 2,363 | +26155.6% | 0.05% | – |
| Q4 2018 | $1,000 | -66.7% | 9 | -88.5% | 0.00% | -100.0% |
| Q2 2017 | $3,000 | – | 78 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 112,689 | $14,541,000 | 14.93% |
| Casdin Capital, LLC | 670,000 | $86,457,000 | 7.95% |
| Logos Global Management LP | 226,002 | $29,163,000 | 7.19% |
| Avoro Capital Advisors LLC | 1,760,000 | $227,110,000 | 6.67% |
| Camber Capital Management LP | 600,000 | $77,424,000 | 3.94% |
| STANSBERRY ASSET MANAGEMENT, LLC | 71,133 | $9,179,000 | 3.74% |
| Eventide Asset Management | 996,000 | $128,524,000 | 3.62% |
| CADIAN CAPITAL MANAGEMENT, LP | 550,000 | $70,972,000 | 3.14% |
| RTW INVESTMENTS, LP | 605,762 | $78,168,000 | 2.95% |
| Consonance Capital Management LP | 356,145 | $45,957,000 | 2.80% |